AstraZeneca sells former blockbuster cholesterol drug for $320 million
By Aakash B AstraZeneca said on Tuesday it would sell rights to its erstwhile blockbuster cholesterol drug, Crestor, to German pharmaceutical company Gruenenthal GmbH for an upfront payment of $320 million as the British drugmaker focuses on its cancer treatments portfolio. Crestor, which brought in revenue of over $5 billion for AstraZeneca in 2015, was […]